Cryopreservation as Optimizing Factor in Therapeutic Effect of Products of Embryofetoplacental Complex (PEFPC) Part 1. Pathology of autoimmune genesis as assessment model of therapeutic effect of PEFPC application

Authors

  • A. N. Goltsev Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkov
  • K. N. Popova Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkov
  • M. A. Sirous Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkov

Keywords:

autoimmune diseases, autoimmune hemolytic anemia, ethyopathogenesis, lymphohemopoietic complex, products of embryofetoplacental complex, cryopreservation

Abstract

The possibility of using model autoimmune diseases for estimating a therapeutic efficiency of cryopreserved products of embryofetoplacental complex (PEFPC) is substantiated. With the example of autoimmune hemolytical anemia there has been shown a multi-profile change of the state of lymphohemopoietic complex of the animals with this pathology. The changes in various links of immune system during pathology development are emphasized. There is noted a possible dependence of their manifestation extent on disorder of harmonic interaction in neuroimmune endocrine block of an organism that stipulates the necessity of treatment of such diseases by preparations with a polyfunctional orientation effect, namely PEFPC.

Downloads

Published

2006-09-15

How to Cite

Goltsev, A. N., Popova, K. N., & Sirous, M. A. (2006). Cryopreservation as Optimizing Factor in Therapeutic Effect of Products of Embryofetoplacental Complex (PEFPC) Part 1. Pathology of autoimmune genesis as assessment model of therapeutic effect of PEFPC application. Problems of Cryobiology and Cryomedicine, 16(3), 326–340. Retrieved from https://cryo.org.ua/journal/index.php/probl-cryobiol-cryomed/article/view/588

Issue

Vol. 16 No. 3 (2006): Problems of Cryobiology

Section

Cryomedicine, Clinical and Experimental Transplantology

License

Copyright (c) 2020 A. N. Goltsev, K. N. Popova, M. A. Sirous

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).